Independent Replication and Metaanalysis of Association Studies Establish TNFSF4 as a Susceptibility Gene Preferentially Associated with the Subset of Anticentromere-positive Patients with Systemic Sclerosis
- 15 March 2012
- journal article
- research article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 39 (5), 997-1003
- https://doi.org/10.3899/jrheum.111270
Abstract
Objective. Independent replication with large cohorts and metaanalysis of genetic associations are necessary to validate genetic susceptibility factors. The known tumor necrosis factor (ligand) superfamily, member 4 gene (TNFSF4) systemic lupus erythematosus (SLE) risk locus has been found to be associated with systemic sclerosis (SSc) in 2 studies, but with discrepancies between them for genotype-phenotype correlation. Our objective was to validate TNFSF4 association with SSc and determine the subset with the higher risk. Methods. Known SLE and SSc TNFSF4 susceptibility variants (rs2205960, rs1234317, rs12039904, rs10912580, and rs844648) were genotyped in 1031 patients with SSc and 1014 controls of French white ancestry. Genotype-phenotype association analysis and metaanalysis of available data were performed, providing a population study of 4989 patients with SSc and 4661 controls, all of European white ancestry. Results. Allelic and genotypic associations were observed for the 5 single-nucleotide polymorphisms (SNP) with the subset of patients with SSc who are positive for anticentromere antibodies (ACA) and only a trend for association with SSc and limited cutaneous SSc. Rs2205960 exhibited the strongest allelic association in ACA+ patients with SSc [p = 0.0015; OR 1.37 (1.12–1.66)], with significant intra-cohort association when compared to patients with SSc positive for ACA. Metaanalysis confirmed overall association with SSc but also raised preferential association with the ACA+ subset and strongest effect with rs2205960 [T allele p = 0.00013; OR 1.33 (1.15–1.54) and TT genotype p = 0.00046; OR 2.02 (1.36–2.98)]. Conclusion. We confirm TNFSF4 as an SSc susceptibility gene and rs2205960 as a putative causal variant with preferential association in the ACA+ SSc subphenotype.Keywords
This publication has 23 references indexed in Scilit:
- Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association StrategyPLoS Genetics, 2011
- C8orf13-BLK is a genetic risk locus for systemic sclerosis and has additive effects with BANK1: Results from a large french cohort and meta-analysisArthritis & Rheumatism, 2011
- Recommendations for publication of genetic association studies inArthritis & RheumatismArthritis & Rheumatism, 2011
- A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohortAnnals Of The Rheumatic Diseases, 2010
- Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosisAnnals Of The Rheumatic Diseases, 2010
- Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic sclerodermaAnnals Of The Rheumatic Diseases, 2010
- Updating the genetics of systemic sclerosisCurrent Opinion in Rheumatology, 2010
- Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndromeGenes & Immunity, 2010
- Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosisAnnals Of The Rheumatic Diseases, 2009
- Meta-analysis of genetic association studiesTrends in Genetics, 2004